TARSUS PHARMACEUTICALS, INC. Variable Lease, Cost
TARSUS PHARMACEUTICALS, INC. (TARS) reported Variable Lease, Cost of $258.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-06
- TARSUS PHARMACEUTICALS, INC. variable lease, cost for the quarter ending 2026-06-30 was $258.00K, a 106.40% increase year-over-year.
- TARSUS PHARMACEUTICALS, INC. variable lease, cost for the quarter ending 2026-03-31 was $325.00K, a 162.10% increase year-over-year.
- TARSUS PHARMACEUTICALS, INC. variable lease, cost for the quarter ending 2025-12-31 was $241.00K, a 92.80% increase year-over-year.
- TARSUS PHARMACEUTICALS, INC. variable lease, cost for the quarter ending 2025-09-30 was $155.00K, a 23.02% increase year-over-year.
- TARSUS PHARMACEUTICALS, INC. variable lease, cost for fiscal 2025 was $645.00K, a 36.65% increase from fiscal 2024.
- TARSUS PHARMACEUTICALS, INC. variable lease, cost for fiscal 2024 was $472.00K, a 20.72% increase from fiscal 2023.
- TARSUS PHARMACEUTICALS, INC. variable lease, cost for fiscal 2023 was $391.00K, a 60.25% increase from fiscal 2022.
- TARSUS PHARMACEUTICALS, INC. variable lease, cost for fiscal 2022 was $244.00K, a 69.44% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $258.00K 10-Q · filed 2026-08-06 | $583.00K 10-Q · filed 2026-08-06 | $824.00K derived: sum of 3 quarters · filed 2026-08-06 | $979.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $325.00K 10-Q · filed 2026-05-06 | $566.00K derived: sum of 2 quarters · filed 2026-05-06 | $721.00K derived: sum of 3 quarters · filed 2026-05-06 | $846.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $241.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $396.00K derived: sum of 2 quarters · filed 2026-02-23 | $521.00K derived: sum of 3 quarters · filed 2026-08-06 | $645.00K 10-K · filed 2026-02-23 |
| 2025-09-30 | $155.00K 10-Q · filed 2025-11-04 | $280.00K derived: sum of 2 quarters · filed 2026-08-06 | $404.00K 10-Q · filed 2025-11-04 | $529.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $125.00K 10-Q · filed 2026-08-06 | $249.00K 10-Q · filed 2026-08-06 | $374.00K derived: sum of 3 quarters · filed 2026-08-06 | $500.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $124.00K 10-Q · filed 2026-05-06 | $249.00K derived: sum of 2 quarters · filed 2026-05-06 | $375.00K derived: sum of 3 quarters · filed 2026-05-06 | $493.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $251.00K derived: sum of 2 quarters · filed 2026-02-23 | $369.00K derived: sum of 3 quarters · filed 2026-02-23 | $472.00K 10-K · filed 2026-02-23 |
| 2024-09-30 | $126.00K 10-Q · filed 2025-11-04 | $244.00K derived: sum of 2 quarters · filed 2025-11-04 | $347.00K 10-Q · filed 2025-11-04 | $442.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $118.00K 10-Q · filed 2025-08-06 | $221.00K 10-Q · filed 2025-08-06 | $316.00K derived: sum of 3 quarters · filed 2026-02-23 | $441.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $103.00K 10-Q · filed 2025-05-01 | $198.00K derived: sum of 2 quarters · filed 2026-02-23 | $323.00K derived: sum of 3 quarters · filed 2026-02-23 | $413.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $220.00K derived: sum of 2 quarters · filed 2026-02-23 | $310.00K derived: sum of 3 quarters · filed 2026-02-23 | $391.00K 10-K · filed 2026-02-23 |
| 2023-09-30 | $125.00K 10-Q · filed 2024-11-13 | $215.00K derived: sum of 2 quarters · filed 2024-11-13 | $296.00K 10-Q · filed 2024-11-13 | $372.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $90.00K 10-Q · filed 2024-08-08 | $171.00K 10-Q · filed 2024-08-08 | $247.00K derived: sum of 3 quarters · filed 2025-02-25 | $314.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $81.00K 10-Q · filed 2024-05-08 | $157.00K derived: sum of 2 quarters · filed 2025-02-25 | $224.00K derived: sum of 3 quarters · filed 2025-02-25 | $286.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $143.00K derived: sum of 2 quarters · filed 2025-02-25 | $205.00K derived: sum of 3 quarters · filed 2025-02-25 | $244.00K 10-K · filed 2025-02-25 |
| 2022-09-30 | $67.00K 10-Q · filed 2023-11-09 | $129.00K derived: sum of 2 quarters · filed 2023-11-09 | $168.00K 10-Q · filed 2023-11-09 | $208.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $62.00K 10-Q · filed 2023-08-10 | $101.00K 10-Q · filed 2023-08-10 | $141.00K derived: sum of 3 quarters · filed 2023-08-10 | $174.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $39.00K 10-Q · filed 2022-05-11 | $79.00K derived: sum of 2 quarters · filed 2023-03-17 | $112.00K derived: sum of 3 quarters · filed 2023-03-17 | $123.00K derived: sum of 4 quarters · filed 2023-03-17 |
| 2021-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $73.00K derived: sum of 2 quarters · filed 2023-03-17 | $84.00K derived: sum of 3 quarters · filed 2023-03-17 | $144.00K 10-K · filed 2023-03-17 |
| 2021-09-30 | $33.00K 10-Q · filed 2022-11-09 | $44.00K derived: sum of 2 quarters · filed 2022-11-09 | $104.00K 10-Q · filed 2022-11-09 | $91.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $11.00K 10-Q · filed 2022-08-11 | $71.00K 10-Q · filed 2022-08-11 | $58.00K derived: sum of 3 quarters · filed 2022-08-11 | $96.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $60.00K 10-Q · filed 2022-05-11 | $47.00K derived: sum of 2 quarters · filed 2022-05-11 | $85.00K derived: sum of 3 quarters · filed 2022-05-11 | $85.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $25.00K derived: sum of 2 quarters · filed 2022-03-14 | $25.00K derived: sum of 3 quarters · filed 2022-03-14 | $25.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $38.00K 10-Q · filed 2021-11-10 | $38.00K derived: sum of 2 quarters · filed 2021-11-10 | $38.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |